{"transactions":[{"id":500961,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Legal Officer"}}],"security":"Stock Option","published_at":"2011-09-14T16:43:18.000Z","date":"2011-09-13","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-11-047799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047799/doc4.xml","form_type":"4"}},{"id":500960,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2011-09-14T16:43:18.000Z","date":"2011-09-13","kind":"sale","acquired":false,"shares":22000,"price":50,"value":1100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-047799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047799/doc4.xml","form_type":"4"}},{"id":500959,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Legal Officer"}}],"security":"Common Stock","published_at":"2011-09-14T16:43:18.000Z","date":"2011-09-13","kind":"exercise","acquired":true,"shares":22000,"price":18.75,"value":412500.0,"ownership":{"direct":true},"balance_after":134999,"source":{"system":"sec-edgar","filing":"0001209191-11-047799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111047799/doc4.xml","form_type":"4"}},{"id":502083,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-08-01T18:30:34.000Z","date":"2011-07-29","kind":"exercise","acquired":false,"shares":7334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":22000,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7334},"source":{"system":"sec-edgar","filing":"0001209191-11-041692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041692/doc4.xml","form_type":"4"}},{"id":502082,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-08-01T18:30:34.000Z","date":"2011-07-29","kind":"sale","acquired":false,"shares":7334,"price":50,"value":366700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-041692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041692/doc4.xml","form_type":"4"}},{"id":502081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-08-01T18:30:34.000Z","date":"2011-07-29","kind":"exercise","acquired":true,"shares":7334,"price":18.75,"value":137512.5,"ownership":{"direct":true},"balance_after":120333,"source":{"system":"sec-edgar","filing":"0001209191-11-041692","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111041692/doc4.xml","form_type":"4"}},{"id":502359,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-07-21T19:22:22.000Z","date":"2011-07-13","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":29334,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-11-040456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111040456/doc4.xml","form_type":"4"}},{"id":502358,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-21T19:22:22.000Z","date":"2011-07-20","kind":"sale","acquired":false,"shares":7333,"price":50.04,"value":366943.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $50.04 (range $50.00 to $50.47)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-040456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111040456/doc4.xml","form_type":"4"}},{"id":502357,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-21T19:22:22.000Z","date":"2011-07-20","kind":"exercise","acquired":true,"shares":7333,"price":18.75,"value":137493.75,"ownership":{"direct":true},"balance_after":120332,"source":{"system":"sec-edgar","filing":"0001209191-11-040456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111040456/doc4.xml","form_type":"4"}},{"id":502511,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-07-14T19:04:16.000Z","date":"2011-07-13","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/13/2011."}],"balance_after":30500,"derivative":{"exercise_price":51.75,"exercise_date":"2011-10-13","expiration_date":"2021-07-12","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001209191-11-039505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039505/doc4.xml","form_type":"4"}},{"id":502510,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-07-14T19:04:16.000Z","date":"2011-07-13","kind":"exercise","acquired":false,"shares":7334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":36667,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7334},"source":{"system":"sec-edgar","filing":"0001209191-11-039505","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039505/doc4.xml","form_type":"4"}},{"id":502509,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-14T19:04:16.000Z","date":"2011-07-13","kind":"sale","acquired":false,"shares":7334,"price":51.92,"value":380781.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $51.92 (range $51.51 to $52.25)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-039505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039505/doc4.xml","form_type":"4"}},{"id":502508,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-14T19:04:16.000Z","date":"2011-07-13","kind":"exercise","acquired":true,"shares":7334,"price":18.75,"value":137512.5,"ownership":{"direct":true},"balance_after":120333,"source":{"system":"sec-edgar","filing":"0001209191-11-039505","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111039505/doc4.xml","form_type":"4"}},{"id":502653,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-07-07T18:21:19.000Z","date":"2011-07-06","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":44001,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-11-038667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111038667/doc4.xml","form_type":"4"}},{"id":502652,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-07T18:21:19.000Z","date":"2011-07-06","kind":"sale","acquired":false,"shares":120,"price":51.73,"value":6207.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $51.73 (range $51.18 to $51.84)."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-038667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111038667/doc4.xml","form_type":"4"}},{"id":502651,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-07T18:21:19.000Z","date":"2011-07-06","kind":"sale","acquired":false,"shares":7213,"price":50.29,"value":362741.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $50.29 (range $50.00 to $50.73)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":113119,"source":{"system":"sec-edgar","filing":"0001209191-11-038667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111038667/doc4.xml","form_type":"4"}},{"id":502650,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-07-07T18:21:19.000Z","date":"2011-07-06","kind":"exercise","acquired":true,"shares":7333,"price":18.75,"value":137493.75,"ownership":{"direct":true},"balance_after":120332,"source":{"system":"sec-edgar","filing":"0001209191-11-038667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111038667/doc4.xml","form_type":"4"}},{"id":502893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-06-30T18:18:30.000Z","date":"2011-06-29","kind":"exercise","acquired":false,"shares":7334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":51334,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7334},"source":{"system":"sec-edgar","filing":"0001209191-11-036876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036876/doc4.xml","form_type":"4"}},{"id":502892,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-30T18:18:30.000Z","date":"2011-06-29","kind":"sale","acquired":false,"shares":5458,"price":51.63,"value":281796.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $51.63 (range $51.02 to $51.88)."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-036876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036876/doc4.xml","form_type":"4"}},{"id":502891,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-30T18:18:30.000Z","date":"2011-06-29","kind":"sale","acquired":false,"shares":1876,"price":50.64,"value":95000.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $50.64 (range $50.37 to $50.94)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":118457,"source":{"system":"sec-edgar","filing":"0001209191-11-036876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036876/doc4.xml","form_type":"4"}},{"id":502890,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-30T18:18:30.000Z","date":"2011-06-29","kind":"exercise","acquired":true,"shares":7334,"price":18.75,"value":137512.5,"ownership":{"direct":true},"balance_after":120333,"source":{"system":"sec-edgar","filing":"0001209191-11-036876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036876/doc4.xml","form_type":"4"}},{"id":502906,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-06-29T19:19:56.000Z","date":"2011-06-28","kind":"exercise","acquired":false,"shares":14667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":58668,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":14667},"source":{"system":"sec-edgar","filing":"0001209191-11-036721","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036721/doc4.xml","form_type":"4"}},{"id":502905,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-29T19:19:56.000Z","date":"2011-06-28","kind":"sale","acquired":false,"shares":14667,"price":50,"value":733350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-036721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036721/doc4.xml","form_type":"4"}},{"id":502904,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-29T19:19:56.000Z","date":"2011-06-28","kind":"exercise","acquired":true,"shares":14667,"price":18.75,"value":275006.25,"ownership":{"direct":true},"balance_after":127666,"source":{"system":"sec-edgar","filing":"0001209191-11-036721","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111036721/doc4.xml","form_type":"4"}},{"id":503249,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-06-10T12:56:22.000Z","date":"2011-06-08","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully vested."}],"balance_after":73335,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-11-033964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111033964/doc4.xml","form_type":"4"}},{"id":503248,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-10T12:56:22.000Z","date":"2011-06-08","kind":"sale","acquired":false,"shares":7333,"price":53.38,"value":391435.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $53.38 (range $52.98 to $54.12)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-033964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111033964/doc4.xml","form_type":"4"}},{"id":503247,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-10T12:56:22.000Z","date":"2011-06-08","kind":"exercise","acquired":true,"shares":7333,"price":18.75,"value":137493.75,"ownership":{"direct":true},"balance_after":120332,"source":{"system":"sec-edgar","filing":"0001209191-11-033964","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111033964/doc4.xml","form_type":"4"}},{"id":503384,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-06-02T20:40:21.000Z","date":"2011-06-01","kind":"exercise","acquired":false,"shares":7334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":80668,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":7334},"source":{"system":"sec-edgar","filing":"0001209191-11-032533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111032533/doc4.xml","form_type":"4"}},{"id":503383,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-02T20:40:21.000Z","date":"2011-06-01","kind":"sale","acquired":false,"shares":1100,"price":54.14,"value":59554.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $54.14 (range $54.00 to $54.50)."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-032533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111032533/doc4.xml","form_type":"4"}},{"id":503382,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-02T20:40:21.000Z","date":"2011-06-01","kind":"sale","acquired":false,"shares":6234,"price":53.59,"value":334080.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $53.59 (range $53.21 to $53.98)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":114099,"source":{"system":"sec-edgar","filing":"0001209191-11-032533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111032533/doc4.xml","form_type":"4"}},{"id":503381,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-06-02T20:40:21.000Z","date":"2011-06-01","kind":"exercise","acquired":true,"shares":7334,"price":18.75,"value":137512.5,"ownership":{"direct":true},"balance_after":120333,"source":{"system":"sec-edgar","filing":"0001209191-11-032533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111032533/doc4.xml","form_type":"4"}},{"id":503658,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-05-26T20:48:57.000Z","date":"2011-05-25","kind":"sale","acquired":false,"shares":2489,"price":56.23,"value":139956.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $56.23 (range $56.01 to $56.46)."}],"balance_after":112999,"source":{"system":"sec-edgar","filing":"0001209191-11-031297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111031297/doc4.xml","form_type":"4"}},{"id":503657,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-05-26T20:48:57.000Z","date":"2011-05-25","kind":"sale","acquired":false,"shares":1577,"price":55.56,"value":87618.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $55.56 (range $55.14 to $55.95)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":115488,"source":{"system":"sec-edgar","filing":"0001209191-11-031297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111031297/doc4.xml","form_type":"4"}},{"id":504874,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2011-05-03T19:05:53.000Z","date":"2011-05-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":24.66,"expiration_date":"2011-12-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-11-025599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111025599/doc4.xml","form_type":"4"}},{"id":504873,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-05-03T19:05:53.000Z","date":"2011-05-02","kind":"sale","acquired":false,"shares":1386,"price":56.01,"value":77629.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $56.01 (range $55.90 to $56.48)."}],"balance_after":116752,"source":{"system":"sec-edgar","filing":"0001209191-11-025599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111025599/doc4.xml","form_type":"4"}},{"id":504872,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-05-03T19:05:53.000Z","date":"2011-05-02","kind":"sale","acquired":false,"shares":3614,"price":55.57,"value":200829.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $55.57 (range $55.06 to $55.88)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":118138,"source":{"system":"sec-edgar","filing":"0001209191-11-025599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111025599/doc4.xml","form_type":"4"}},{"id":504871,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-05-03T19:05:53.000Z","date":"2011-05-02","kind":"exercise","acquired":true,"shares":5000,"price":24.66,"value":123300.0,"ownership":{"direct":true},"balance_after":121752,"source":{"system":"sec-edgar","filing":"0001209191-11-025599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111025599/doc4.xml","form_type":"4"}},{"id":505918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-04-04T18:53:14.000Z","date":"2011-03-31","kind":"other","acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trustee of Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Kenneth S. Boger is the trustee for trusts established for the benefit of the three adult children of Joshua S. Boger (a director of the issuer) that held 207,500 shares of common stock.  On March 31, 2011, one of Joshua S. Boger's children withdrew 33,333 shares of Vertex common stock from a trust formed for his benefit.  Kenneth S. Boger disclaims beneficial ownership of the 174,167 shares held in the trusts."}],"balance_after":174167,"source":{"system":"sec-edgar","filing":"0001209191-11-020912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919111020912/doc4.xml","form_type":"4"}},{"id":509353,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2011-02-07T19:53:50.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/03/2011."}],"balance_after":45750,"derivative":{"exercise_price":38.8,"exercise_date":"2011-05-03","expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0000875320-11-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000009/edgar.xml","form_type":"4"}},{"id":509352,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2011-02-07T19:53:50.000Z","date":"2011-02-03","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/3/2015, subject to (i) earlier acceleration of 50% of shares upon (A) receiving U.S. and E.U. marketing approval for VX-770 or (B) reaching specified telaprevir sales levels during 18 months following its U.S. launch; and (ii) earlier acceleration of 50% of shares upon  (1) acceptance by the FDA of an NDA for a treatment regimen that includes telaprevir and VX-222; (2) initiation of a pivotal trial for a drug candidate for which the Company has U.S. commercialization rights in an indication that is not HCV infection or CF; or (3) reaching specified telaprevir sales levels during 18 months following its U.S. launch."}],"balance_after":116752,"source":{"system":"sec-edgar","filing":"0000875320-11-000009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532011000009/edgar.xml","form_type":"4"}},{"id":516202,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2010-07-16T19:50:53.000Z","date":"2010-07-14","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/14/2010."}],"balance_after":30500,"derivative":{"exercise_price":33.82,"exercise_date":"2010-10-14","expiration_date":"2020-07-13","underlying":"Common STock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-10-000040","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000040/edgar.xml","form_type":"4"}},{"id":523494,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2010-02-08T18:43:05.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":76250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock option under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years."}],"balance_after":76250,"derivative":{"exercise_price":39.05,"exercise_date":"2010-05-04","expiration_date":"2020-02-03","underlying":"Common Stock","underlying_shares":76250},"source":{"system":"sec-edgar","filing":"0000875320-10-000008","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000008/edgar.xml","form_type":"4"}},{"id":523493,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2010-02-08T18:43:05.000Z","date":"2010-02-04","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/4/2014, subject to 50% acceleration upon receiving U.S. marketing approval for telaprevir; and to 50% acceleration upon either (a) reaching specified telaprevir sales levels during 18 months following its U.S. launch or (b) launch of any additional drug beyond telaprevir prior to December 31, 2012."}],"balance_after":106023,"source":{"system":"sec-edgar","filing":"0000875320-10-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532010000008/edgar.xml","form_type":"4"}},{"id":527446,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-10-26T20:31:09.000Z","date":"2009-10-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option under 2006 Stock and Option Plan, vesting on 10/22/2014, subject to 100% acceleration upon receiving marketing approval from the FDA for telaprevir."}],"balance_after":30000,"derivative":{"exercise_price":33,"exercise_date":"2014-10-22","expiration_date":"2019-10-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000875320-09-000089","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000089/edgar.xml","form_type":"4"}},{"id":529081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-08-04T19:24:26.000Z","date":"2009-08-03","kind":"exercise","acquired":false,"shares":3024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.16,"expiration_date":"2015-07-19","underlying":"Common Stock","underlying_shares":3024},"source":{"system":"sec-edgar","filing":"0000875320-09-000073","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000073/edgar.xml","form_type":"4"}},{"id":529080,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-08-04T19:24:26.000Z","date":"2009-08-03","kind":"exercise","acquired":false,"shares":17820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":17820},"source":{"system":"sec-edgar","filing":"0000875320-09-000073","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000073/edgar.xml","form_type":"4"}},{"id":529079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-08-04T19:24:26.000Z","date":"2009-08-03","kind":"sale","acquired":false,"shares":20844,"price":36.02,"value":750800.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $36.02 (range $36.00 to $36.26)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":95857,"source":{"system":"sec-edgar","filing":"0000875320-09-000073","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000073/edgar.xml","form_type":"4"}},{"id":529078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-08-04T19:24:26.000Z","date":"2009-08-03","kind":"exercise","acquired":true,"shares":3024,"price":17.16,"value":51891.84,"ownership":{"direct":true},"balance_after":116701,"source":{"system":"sec-edgar","filing":"0000875320-09-000073","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000073/edgar.xml","form_type":"4"}},{"id":529077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-08-04T19:24:26.000Z","date":"2009-08-03","kind":"exercise","acquired":true,"shares":17820,"price":18.75,"value":334125.0,"ownership":{"direct":true},"balance_after":113677,"source":{"system":"sec-edgar","filing":"0000875320-09-000073","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000073/edgar.xml","form_type":"4"}},{"id":529255,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":false,"shares":1547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":10.41,"expiration_date":"2015-02-02","underlying":"Common Stock","underlying_shares":1547},"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529254,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":false,"shares":4173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":3024,"derivative":{"exercise_price":17.16,"expiration_date":"2015-07-19","underlying":"Common Stock","underlying_shares":4173},"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529253,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":false,"shares":14179,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":17820,"derivative":{"exercise_price":18.75,"expiration_date":"2011-09-23","underlying":"Common Stock","underlying_shares":14179},"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529252,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"sale","acquired":false,"shares":19898,"price":36,"value":716328.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under Rule 10b5-1."}],"balance_after":95857,"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529251,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":true,"shares":1547,"price":10.41,"value":16104.27,"ownership":{"direct":true},"balance_after":115755,"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529250,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":true,"shares":4173,"price":17.16,"value":71608.68,"ownership":{"direct":true},"balance_after":114208,"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529249,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-07-29T18:36:56.000Z","date":"2009-07-28","kind":"exercise","acquired":true,"shares":14178,"price":18.75,"value":265837.5,"ownership":{"direct":true},"balance_after":110035,"source":{"system":"sec-edgar","filing":"0000875320-09-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000071/edgar.xml","form_type":"4"}},{"id":529427,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2009-07-20T19:27:40.000Z","date":"2009-07-16","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/16/09."}],"balance_after":30500,"derivative":{"exercise_price":33.28,"exercise_date":"2009-10-16","expiration_date":"2019-07-15","underlying":"Common stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-09-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000063/edgar.xml","form_type":"4"}},{"id":529804,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":11203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":1547,"derivative":{"exercise_price":10.41,"expiration_date":"2015-02-02","underlying":"Common Stock","underlying_shares":11203},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529803,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":10803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":7197,"derivative":{"exercise_price":17.16,"exercise_date":"2005-10-20","expiration_date":"2015-07-19","underlying":"Common Stock","underlying_shares":10803},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529802,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.27,"expiration_date":"2014-10-06","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529801,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.07,"expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529800,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":29998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.6,"expiration_date":"2013-01-17","underlying":"Common Stock","underlying_shares":29998},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529799,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":3160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.6,"expiration_date":"2013-01-17","underlying":"Common Stock","underlying_shares":3160},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529798,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":4821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.87,"expiration_date":"2012-07-21","underlying":"Common Stock","underlying_shares":4821},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529797,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":false,"shares":27316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":15.87,"expiration_date":"2012-07-21","underlying":"Common Stock","underlying_shares":27316},"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529796,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"sale","acquired":false,"shares":108001,"price":36,"value":3888036.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under Rule 10b5-1."}],"balance_after":95857,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529795,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":11203,"price":10.41,"value":116623.23,"ownership":{"direct":true},"balance_after":203858,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529794,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":10803,"price":17.16,"value":185379.48,"ownership":{"direct":true},"balance_after":192655,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529793,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common  Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":18000,"price":11.27,"value":202860.0,"ownership":{"direct":true},"balance_after":181852,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529792,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":2700,"price":9.07,"value":24489.0,"ownership":{"direct":true},"balance_after":163852,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529791,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":29998,"price":15.6,"value":467968.8,"ownership":{"direct":true},"balance_after":161152,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529790,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":3160,"price":15.6,"value":49296.0,"ownership":{"direct":true},"balance_after":131154,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529789,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common  Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":4821,"price":15.87,"value":76509.27,"ownership":{"direct":true},"balance_after":127994,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":529788,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-06-30T20:05:06.000Z","date":"2009-06-26","kind":"exercise","acquired":true,"shares":27316,"price":15.87,"value":433504.92,"ownership":{"direct":true},"balance_after":123173,"source":{"system":"sec-edgar","filing":"0000875320-09-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000051/edgar.xml","form_type":"4"}},{"id":530893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-05-11T18:53:14.000Z","date":"2009-05-07","kind":"sale","acquired":false,"shares":11826,"price":28.89,"value":341653.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales repoted on this line occurred at a weighted average price of $28.89 (range $28.70 to $29.20)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":95857,"source":{"system":"sec-edgar","filing":"0000875320-09-000025","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000025/edgar.xml","form_type":"4"}},{"id":533603,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2009-02-06T21:15:30.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/09."}],"balance_after":45750,"derivative":{"exercise_price":33.55,"exercise_date":"2009-05-05","expiration_date":"2019-02-04","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0000875320-09-000004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000004/edgar.xml","form_type":"4"}},{"id":533602,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2009-02-06T21:15:30.000Z","date":"2009-02-05","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/5/2013, subject to 50% acceleration upon filing a new drug application with the FDA for telaprevir and 50% acceleration upon the approval of a new drug application for telaprevir."}],"balance_after":107683,"source":{"system":"sec-edgar","filing":"0000875320-09-000004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532009000004/edgar.xml","form_type":"4"}},{"id":535556,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2008-11-19T17:31:41.000Z","date":"2008-11-18","kind":"sale","acquired":false,"shares":15000,"price":26.69,"value":400350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Open market sales reported on this line occurred at a wieghted average price of $26.69 (range $26.60 to $26.82)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":97517,"source":{"system":"sec-edgar","filing":"0000875320-08-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000085/edgar.xml","form_type":"4"}},{"id":538694,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2008-07-25T14:57:52.000Z","date":"2008-07-24","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008."}],"balance_after":30500,"derivative":{"exercise_price":32.16,"exercise_date":"2008-10-24","expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-08-000053","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000053/edgar.xml","form_type":"4"}},{"id":559419,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2008-02-11T20:48:17.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval."}],"balance_after":30500,"derivative":{"exercise_price":18.93,"exercise_date":"2008-05-07","expiration_date":"2018-02-06","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-08-000004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000004/edgar.xml","form_type":"4"}},{"id":559418,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2008-02-11T20:48:17.000Z","date":"2008-02-07","kind":"grant","acquired":true,"shares":8133,"price":0.01,"value":81.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":112160,"source":{"system":"sec-edgar","filing":"0000875320-08-000004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532008000004/edgar.xml","form_type":"4"}},{"id":575525,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2007-07-16T17:57:55.000Z","date":"2007-07-12","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/12/2007."}],"balance_after":30500,"derivative":{"exercise_price":28.84,"exercise_date":"2007-10-12","expiration_date":"2017-07-11","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-07-000074","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000074/edgar.xml","form_type":"4"}},{"id":580969,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-05-08T18:55:32.000Z","date":"2007-05-07","kind":"sale","acquired":false,"shares":12684,"price":30.6,"value":388130.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under rule 10b5-1."}],"balance_after":103677,"source":{"system":"sec-edgar","filing":"0000875320-07-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000045/edgar.xml","form_type":"4"}},{"id":581874,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2007-05-01T15:58:52.000Z","date":"2007-04-30","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4  years from 2/3/2005."}],"balance_after":12750,"derivative":{"exercise_price":10.41,"exercise_date":"2005-05-03","expiration_date":"2015-02-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000875320-07-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000041/edgar.xml","form_type":"4"}},{"id":581873,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-05-01T15:58:52.000Z","date":"2007-04-30","kind":"sale","acquired":false,"shares":12000,"price":31.35,"value":376200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under rule 10b5-1."}],"balance_after":116361,"source":{"system":"sec-edgar","filing":"0000875320-07-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000041/edgar.xml","form_type":"4"}},{"id":581872,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-05-01T15:58:52.000Z","date":"2007-04-30","kind":"exercise","acquired":true,"shares":12000,"price":10.41,"value":124920.0,"ownership":{"direct":true},"balance_after":128361,"source":{"system":"sec-edgar","filing":"0000875320-07-000041","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000041/edgar.xml","form_type":"4"}},{"id":583275,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Options","published_at":"2007-04-02T20:32:05.000Z","date":"2007-03-30","kind":"exercise","acquired":false,"shares":11700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4  years from 12/11/2003."}],"balance_after":2700,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":11700},"source":{"system":"sec-edgar","filing":"0000875320-07-000032","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000032/edgar.xml","form_type":"4"}},{"id":583274,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-04-02T20:32:05.000Z","date":"2007-03-30","kind":"sale","acquired":false,"shares":11700,"price":28.08,"value":328536.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Boger's company approved trading plan established under rule 10b5-1."}],"balance_after":116361,"source":{"system":"sec-edgar","filing":"0000875320-07-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000032/edgar.xml","form_type":"4"}},{"id":583273,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-04-02T20:32:05.000Z","date":"2007-03-30","kind":"exercise","acquired":true,"shares":11700,"price":9.07,"value":106119.0,"ownership":{"direct":true},"balance_after":128061,"source":{"system":"sec-edgar","filing":"0000875320-07-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000032/edgar.xml","form_type":"4"}},{"id":588218,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2007-01-26T20:29:36.000Z","date":"2007-01-24","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 01/24/2007."}],"balance_after":45750,"derivative":{"exercise_price":36.3,"exercise_date":"2007-04-24","expiration_date":"2017-01-23","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0000875320-07-000011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000011/edgar.xml","form_type":"4"}},{"id":588217,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2007-01-26T20:29:36.000Z","date":"2007-01-24","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 2006 Stock and Option Plan, vesting on 1/24/2011, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":116361,"source":{"system":"sec-edgar","filing":"0000875320-07-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532007000011/edgar.xml","form_type":"4"}},{"id":603508,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2006-07-24T17:39:12.000Z","date":"2006-07-20","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2006."}],"balance_after":369445,"derivative":{"exercise_price":35.35,"exercise_date":"2006-10-20","expiration_date":"2016-07-19","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0000875320-06-000062","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000062/edgar.xml","form_type":"4"}},{"id":619820,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2006-02-06T21:35:42.000Z","date":"2006-02-02","kind":"grant","acquired":true,"shares":73500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/02/2006."}],"balance_after":338945,"derivative":{"exercise_price":35.64,"exercise_date":"2006-05-02","expiration_date":"2016-02-01","underlying":"Common Stock","underlying_shares":73500},"source":{"system":"sec-edgar","filing":"0000875320-06-000011","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000011/edgar.xml","form_type":"4"}},{"id":619819,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common  Stock","published_at":"2006-02-06T21:35:42.000Z","date":"2006-02-02","kind":"grant","acquired":true,"shares":12200,"price":0.01,"value":122.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting on 2/2/2010, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":105529,"source":{"system":"sec-edgar","filing":"0000875320-06-000011","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532006000011/edgar.xml","form_type":"4"}},{"id":635917,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2005-07-22T19:01:05.000Z","date":"2005-07-20","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2005."}],"balance_after":265445,"derivative":{"exercise_price":17.16,"exercise_date":"2005-10-20","expiration_date":"2015-07-19","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000875320-05-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000041/edgar.xml","form_type":"4"}},{"id":646402,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2005-02-07T21:29:37.000Z","date":"2005-02-03","kind":"grant","acquired":true,"shares":24750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/03/2005."}],"balance_after":247445,"derivative":{"exercise_price":10.41,"exercise_date":"2005-05-03","expiration_date":"2015-02-02","underlying":"Common Stock","underlying_shares":24750},"source":{"system":"sec-edgar","filing":"0000875320-05-000006","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000006/edgar.xml","form_type":"4"}},{"id":646401,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common  Stock","published_at":"2005-02-07T21:29:37.000Z","date":"2005-02-03","kind":"grant","acquired":true,"shares":5700,"price":0.01,"value":57.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting on 2/3/2009, subject to acceleration upon achievement of certain performance-based milestones."}],"balance_after":91620,"source":{"system":"sec-edgar","filing":"0000875320-05-000006","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532005000006/edgar.xml","form_type":"4"}},{"id":652668,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2004-10-12T18:35:30.000Z","date":"2004-10-07","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years."}],"balance_after":222695,"derivative":{"exercise_price":11.27,"exercise_date":"2005-01-07","expiration_date":"2014-10-06","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000875320-04-000104","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000104/edgar.xml","form_type":"4"}},{"id":656979,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Common Stock","published_at":"2004-05-10T19:59:02.000Z","date":"2004-05-06","kind":"grant","acquired":true,"shares":65000,"price":0.01,"value":650.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant made under 1996 Stock and Option Plan, vesting 50% on May 6, 2009, subject to acceleration upon achievement of a performance-based milestone based on Company profitability, and 50% on May 6, 2007."}],"balance_after":85920,"source":{"system":"sec-edgar","filing":"0000875320-04-000047","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532004000047/edgar.xml","form_type":"4"}},{"id":663602,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16840,"kind":"person","name":"BOGER KENNETH S","position":1,"cik":"0001046336","reported_name":"BOGER KENNETH S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & General Counsel"}}],"security":"Stock Option","published_at":"2003-12-15T21:16:24.000Z","date":"2003-12-11","kind":"grant","acquired":true,"shares":14400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 12/11/2003."}],"balance_after":204695,"derivative":{"exercise_price":9.07,"exercise_date":"2004-03-11","expiration_date":"2013-12-10","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0000875320-03-000054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532003000054/edgar.xml","form_type":"4"}}],"next_cursor":"2003-12-15T21:16:24.000000Z,663602"}